<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=1000083763474443&amp;ev=PageView&amp;noscript=1">

Download our Perspective

Ranfac CEO Harlan Adler discusses the company's strategic pivot from contract manufacturing to owning clinical technologies via its first acquisition, Cervos, focusing on patient-derived regenerative medicine. To learn more, read our article!

Article PDFs - Ranfac